Selecta Biosciences, Inc. develops biopharmaceutical treatments. The Company produces nanoparticle immunomodulatory drugs and vaccines, which delivers bioactive molecules to specific immune cells in the body. Selecta Biosciences operates in the United States.
more
Refresh
No publications yet
Add Selecta Biosciences to your Watchlist to get alerts on new publications